Quality indicators in surgical oncology: systematic review of measures used to compare quality across hospitals.


Journal

BJS open
ISSN: 2474-9842
Titre abrégé: BJS Open
Pays: England
ID NLM: 101722685

Informations de publication

Date de publication:
01 Mar 2024
Historique:
received: 17 10 2023
revised: 16 11 2023
accepted: 17 12 2023
medline: 25 3 2024
pubmed: 22 3 2024
entrez: 21 3 2024
Statut: ppublish

Résumé

Measurement and reporting of quality indicators at the hospital level has been shown to improve outcomes and support patient choice. Although there are many studies validating individual quality indicators, there has been no systematic approach to understanding what quality indicators exist for surgical oncology and no standardization for their use. The aim of this study was to review quality indicators used to assess variation in quality in surgical oncology care across hospitals or regions. It also sought to describe the aims of these studies and what, if any, feedback was offered to the analysed groups. A literature search was performed to identify studies published between 1 January 2000 and 23 October 2023 that applied surgical quality indicators to detect variation in cancer care at the hospital or regional level. A total of 89 studies assessed 91 unique quality indicators that fell into the following Donabedian domains: process indicators (58; 64%); outcome indicators (26; 29%); structure indicators (6; 7%); and structure and outcome indicators (1; 1%). Purposes of evaluating variation included: identifying outliers (43; 48%); comparing centres with a benchmark (14; 16%); and supplying evidence of practice variation (29; 33%). Only 23 studies (26%) reported providing the results of their analyses back to those supplying data. Comparisons of quality in surgical oncology within and among hospitals and regions have been undertaken in high-income countries. Quality indicators tended to be process measures and reporting focused on identifying outlying hospitals. Few studies offered feedback to data suppliers.

Sections du résumé

BACKGROUND BACKGROUND
Measurement and reporting of quality indicators at the hospital level has been shown to improve outcomes and support patient choice. Although there are many studies validating individual quality indicators, there has been no systematic approach to understanding what quality indicators exist for surgical oncology and no standardization for their use. The aim of this study was to review quality indicators used to assess variation in quality in surgical oncology care across hospitals or regions. It also sought to describe the aims of these studies and what, if any, feedback was offered to the analysed groups.
METHODS METHODS
A literature search was performed to identify studies published between 1 January 2000 and 23 October 2023 that applied surgical quality indicators to detect variation in cancer care at the hospital or regional level.
RESULTS RESULTS
A total of 89 studies assessed 91 unique quality indicators that fell into the following Donabedian domains: process indicators (58; 64%); outcome indicators (26; 29%); structure indicators (6; 7%); and structure and outcome indicators (1; 1%). Purposes of evaluating variation included: identifying outliers (43; 48%); comparing centres with a benchmark (14; 16%); and supplying evidence of practice variation (29; 33%). Only 23 studies (26%) reported providing the results of their analyses back to those supplying data.
CONCLUSION CONCLUSIONS
Comparisons of quality in surgical oncology within and among hospitals and regions have been undertaken in high-income countries. Quality indicators tended to be process measures and reporting focused on identifying outlying hospitals. Few studies offered feedback to data suppliers.

Identifiants

pubmed: 38513280
pii: 7633090
doi: 10.1093/bjsopen/zrae009
pmc: PMC10957165
pii:
doi:

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : World Health Organization
ID : 001
Pays : International

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of BJS Foundation Ltd.

Références

Ann Surg. 2013 Mar;257(3):483-9
pubmed: 23299518
Eur J Surg Oncol. 2021 Sep;47(9):2384-2389
pubmed: 33985828
JAMA Surg. 2023 Nov 1;158(11):1195-1202
pubmed: 37728906
Epidemiol Prev. 2015 May-Jun;39(3 Suppl 1):40-7
pubmed: 26405775
J Am Coll Surg. 2020 Jun;230(6):1008-1018.e5
pubmed: 32142927
Med Care Res Rev. 2017 Aug;74(4):379-403
pubmed: 27357394
Cochrane Database Syst Rev. 2018 Sep 06;9:CD004538
pubmed: 30188566
Jt Comm J Qual Patient Saf. 2015 May;41(5):199-204
pubmed: 25977246
Gut. 2013 Mar;62(3):423-9
pubmed: 22345658
J Clin Endocrinol Metab. 2013 Oct;98(10):4063-71
pubmed: 23966243
J Thorac Cardiovasc Surg. 2021 Sep;162(3):649-660.e8
pubmed: 34144822
Ann Surg Oncol. 2020 Dec;27(13):5039-5046
pubmed: 32729047
Surgery. 2011 Oct;150(4):635-42
pubmed: 22000174
Arch Surg. 2012 Jun;147(6):505-11
pubmed: 22351873
Ann Thorac Surg. 2014 Jul;98(1):175-81; discussion 182
pubmed: 24793691
J Am Coll Surg. 2014 Sep;219(3):450-9
pubmed: 25026874
Health Aff (Millwood). 2003 Mar-Apr;22(2):84-94
pubmed: 12674410
J Thorac Cardiovasc Surg. 2019 Aug;158(2):570-578.e3
pubmed: 31056356
Lancet Oncol. 2021 Feb;22(2):182-189
pubmed: 33485458
Gynecol Oncol. 2023 Jul;174:89-97
pubmed: 37167897
J Med Imaging Radiat Oncol. 2022 Mar;66(2):249-257
pubmed: 35243788
Int J Colorectal Dis. 2019 May;34(5):889-898
pubmed: 30900012
Ann Surg Oncol. 2014 Aug;21(8):2659-66
pubmed: 24748161
J Urol. 2017 Aug;198(2):322-328
pubmed: 28257783
Rand Health Q. 2012 Dec 1;1(4):6
pubmed: 28083213
BMJ. 2020 Feb 27;368:m213
pubmed: 32107249
Ann Thorac Surg. 2014 Mar;97(3):973-9; discussion 978-9
pubmed: 24480256
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S522-8
pubmed: 25986872
JAMA Surg. 2014 Dec;149(12):1272-7
pubmed: 25337956
Medicine (Baltimore). 2016 Feb;95(8):e2913
pubmed: 26937934
Colorectal Dis. 2013 Jun;15(6):689-94
pubmed: 23398663
Surg Oncol. 2011 Jun;20(2):e72-7
pubmed: 21071208
BMJ. 2012 Jul 12;345:e4505
pubmed: 22791786
Ann Surg Oncol. 2013 Jul;20(7):2117-23
pubmed: 23417434
Int J Gynecol Cancer. 2023 Apr 3;33(4):534-542
pubmed: 36581486
Am J Surg. 2018 Jan;215(1):66-70
pubmed: 28599835
J Thorac Cardiovasc Surg. 2023 Jul;166(1):241-250.e3
pubmed: 36456358
BJOG. 2018 Jun;125(7):857-865
pubmed: 29105913
Breast Cancer Res Treat. 2012 Jan;131(2):691-8
pubmed: 21987038
Eur J Surg Oncol. 2011 Apr;37(4):357-63
pubmed: 21292434
Curr Oncol. 2021 Jan 19;28(1):581-592
pubmed: 33478040
BMJ. 2017 Sep 21;358:j4008
pubmed: 28935701
Int J Qual Health Care. 2018 May 01;30(4):306-312
pubmed: 29506181
Gut. 2011 Jun;60(6):806-13
pubmed: 21486939
BMJ. 2018 May 2;361:k1581
pubmed: 29720371
Colorectal Dis. 2023 May;25(5):861-871
pubmed: 36587285
Eur J Surg Oncol. 2013 Oct;39(10):1063-70
pubmed: 23871573
J Am Coll Surg. 2009 Nov;209(5):557-64
pubmed: 19854394
Lancet. 2004 Apr 3;363(9415):1147-54
pubmed: 15064036
JAMA Surg. 2019 Jun 1;154(6):516-523
pubmed: 30785616
BMC Health Serv Res. 2010 Jan 27;10:27
pubmed: 20105287
Med Care. 2003 Jan;41(1 Suppl):I30-8
pubmed: 12544814
Ann Surg. 2020 Jan;271(1):155-162
pubmed: 31274651
Gut. 2008 Dec;57(12):1690-7
pubmed: 18535029
Value Health. 2020 Sep;23(9):1191-1199
pubmed: 32940237
Am J Surg. 2017 Mar;213(3):548-552
pubmed: 27939006
Eur Urol. 2016 Nov;70(5):854-861
pubmed: 27113032
Arch Surg. 2011 Oct;146(10):1128-34
pubmed: 21690439
Urol Oncol. 2018 Feb;36(2):80.e1-80.e6
pubmed: 29031420
Clin Oncol (R Coll Radiol). 2018 Jul;30(7):e67-e73
pubmed: 29680734
Health Aff (Millwood). 2004 Jan-Jun;Suppl Web Exclusives:W4-184-97
pubmed: 15451981
Front Med (Lausanne). 2023 Mar 14;10:1110977
pubmed: 36999073
Lancet. 2013 Nov 16;382(9905):1674-7
pubmed: 23831144
J Natl Cancer Inst. 2006 Nov 15;98(22):1623-33
pubmed: 17105985
Surg Open Sci. 2023 Sep 13;16:37-43
pubmed: 37766798
JAMA Surg. 2023 Jan 1;158(1):e225461
pubmed: 36350616
Ann Thorac Surg. 2017 Dec;104(6):1872-1880
pubmed: 29106886
BMJ Qual Saf. 2013 Sep;22(9):759-67
pubmed: 23687168
Ann Intern Med. 2008 Jan 15;148(2):111-23
pubmed: 18195336
Dis Colon Rectum. 2020 Jan;63(1):53-59
pubmed: 31633602
Ann Thorac Surg. 2018 Aug;106(2):390-397
pubmed: 29689237
Ann Surg Oncol. 2014 Dec;21(13):4075-80
pubmed: 25001097
Eur J Cancer Care (Engl). 2018 Nov;27(6):e12881
pubmed: 30028054
J Surg Oncol. 2018 Sep;118(4):694-703
pubmed: 30129674
Ann Thorac Surg. 2017 Oct;104(4):1161-1170
pubmed: 28709665
Lancet Oncol. 2021 May;22(5):e207-e215
pubmed: 33676600
Eur Urol. 2017 Sep;72(3):379-386
pubmed: 28511884
PLoS One. 2014 Feb 18;9(2):e88737
pubmed: 24558418
Surgery. 2014 Jul;156(1):190-7
pubmed: 24929768
BMC Health Serv Res. 2016 Jul 22;16:296
pubmed: 27448999
J Thorac Cardiovasc Surg. 2015 May;149(5):1365-71; discussion 1371-3.e3
pubmed: 25791948
Curr Oncol. 2021 Jun 16;28(3):2239-2247
pubmed: 34208635
J Oncol Pract. 2011 Jul;7(4):247-51
pubmed: 22043190
Int J Qual Health Care. 2002 Oct;14(5):411-8
pubmed: 12389807
JAMA. 2012 Feb 1;307(5):467-75
pubmed: 22298678
Ann Thorac Surg. 2021 Apr;111(4):1125-1132
pubmed: 32853566
Lancet Oncol. 2024 Feb;25(2):e63-e72
pubmed: 38301704
Health Serv Manage Res. 2009 Feb;22(1):39-49
pubmed: 19182097
Breast Cancer Res Treat. 2007 Apr;102(2):219-26
pubmed: 17028985
Ann Thorac Surg. 2017 Jun;103(6):1715-1722
pubmed: 28347532
J Surg Educ. 2011 Jul-Aug;68(4):258-65
pubmed: 21708361
Ann Intern Med. 2016 Mar 15;164(6):435-41
pubmed: 26903136
J Clin Oncol. 2014 Sep 20;32(27):2967-74
pubmed: 25092785
Milbank Mem Fund Q. 1966 Jul;44(3):Suppl:166-206
pubmed: 5338568
J Clin Oncol. 2008 Aug 1;26(22):3735-42
pubmed: 18669460
J Am Coll Surg. 2014 Oct;219(4):638-45.e1
pubmed: 25086813
J Thorac Cardiovasc Surg. 2018 Jun;155(6):2658-2671.e1
pubmed: 29534904

Auteurs

Megan McLeod (M)

Department of Health Policy, London School of Economics and Political Science, London, UK.
Department of Otolaryngology-Head & Neck Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Kari Leung (K)

Department of Oncology, Guy's & St Thomas' NHS Trust, London, UK.

C S Pramesh (CS)

Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.

Peter Kingham (P)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Miriam Mutebi (M)

Department of Surgery, Aga Khan University, Nairobi, Kenya.

Julie Torode (J)

Institute of Cancer Policy, Centre for Cancer, Society & Public Health, King's College London, London, UK.

Andre Ilbawi (A)

Department of Universal Health Coverage, World Health Organization, Geneva, Switzerland.

Jade Chakowa (J)

City Cancer Challenge, Geneva, Switzerland.

Richard Sullivan (R)

Institute of Cancer Policy, Global Oncology Group, Centre for Cancer, Society & Public Health, King's College London, London, UK.

Ajay Aggarwal (A)

Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH